In the same vein as weather forecast models that predict developing storms, researchers now have developed a method to ...

ClaimsFiler, a FREE shareholder information service, reminds investors that they have until August 12, 2025 to file lead plaintiff applications in a ...

During a live event, Christine Bestvina, MD, discussed trials of KRAS inhibitors plus immunotherapy in patients with ...

Tempus AI is a growth stock that is down 31% from all-time highs. Here's why TEM AI stock could be a part of your TFSA ...

Digital health startups in the city saw an uptick in funding in the first half of the year as late-stage life science and ...

TEM stock rallies 7.3% after the FDA clears its second cardiology AI tool, witnessing a 48% surge in just three months.

Given the company’s popularity among hedge funds and the bullish sentiment surrounding it, Tempus AI, Inc. (NASDAQ:TEM) makes ...

The global AI infrastructure market is projected to grow at a CAGR of 29.1%, reaching $356.14 billion by 2032 from $36.59 ...

Key Takeaways Tempus AI stock shows 15–32% upside potential based on analyst forecasts.The company leads in using artificial ...

Rep. Nancy Pelosi (D-California) is proving that she means business when it comes to investing. In a staggering financial turn, the former House Speaker and her venture capitalist husband, Paul Pelosi ...

An AI health care stock backed by Nancy Pelosi and Cathie Wood is drawing criticism from Jim Cramer.